Stay updated on Carfilzomib, Iberdomide, Dexamethasone Clinical Trial
Sign up to get notified when there's something new on the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page.

Latest updates to the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov page footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now displays a 403 Forbidden error page for the study record, instead of listing study details; a Home link is shown as part of the default error page.SummaryDifference22%

- Check26 days agoChange DetectedRevision tag updated from v3.6.6 to v3.7.0, signaling a small internal update to the page rather than a substantive change to study details or results.SummaryDifference0.0%

- Check33 days agoChange DetectedRemoval of the disease tag 'Multiple myeloma' and the related topics header including 'MedlinePlus Genetics' reduces disease-specific tagging and access to genetics resources on the page; this changes how the study page is surfaced for disease searches and link navigation.SummaryDifference0.1%

- Check41 days agoChange DetectedExpanded related topics by adding 'Multiple myeloma' and 'MedlinePlus Genetics' in the related topics section. Updated the page revision tag from v3.6.5 to v3.6.6.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page's revision tag was updated to v3.6.5, and certain glossary/topic references (Multiple myeloma, related topics: MedlinePlus Genetics) as well as the prior revision tag (v3.6.4) were removed, indicating a cleanup of non-core page metadata.SummaryDifference0.2%

Stay in the know with updates to Carfilzomib, Iberdomide, Dexamethasone Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page.